Progress in Delivery of siRNA-Based Therapeutics Employing Nano-Vehicles for Treatment of Prostate Cancer

Prostate cancer (PCa) accounts for a high number of deaths in males with no available curative treatments. Patients with PCa are commonly diagnosed in advanced stages due to the lack of symptoms in the early stages. Recently, the research focus was directed toward gene editing in cancer therapy. Sma...

Descripció completa

Dades bibliogràfiques

Autors principals:	Milad Ashrafizadeh, Kiavash Hushmandi, Ebrahim Rahmani Moghadam, Vahideh Zarrin, Sharareh Hosseinzadeh Kashani, Saied Bokaie, Masoud Najafi, Shima Tavakol, Reza Mohammadinejad, Noushin Nabavi, Chia-Ling Hsieh, Atefeh Zarepour, Ehsan Nazarzadeh Zare, Ali Zarrabi, Pooyan Makvandi
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2020-08-01
Col·lecció:	Bioengineering
Matèries:	small interfering RNA (siRNA) prostate cancer gene therapy nanoparticle delivery systems cancer therapy
Accés en línia:	https://www.mdpi.com/2306-5354/7/3/91
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!